Extragastrointestinal stromal tumors (EGISTs), which are neoplasms outside the digestive tract, are predominantly observed in the greater omentum and retroperitoneum.
The clinicopathological and molecular characteristics of EGISTs are similar to those of gastrointestinal stromal tumors (GISTs). EGISTs originating from the prostate are extremely rare. In this study, we report a case of a prostatic EGIST in a 39-year-old male, who presented with frequency, urgency, dysuria and a prostatic mass. A 10-core transrectal ultrasound-guided prostate biopsy was performed, and the histological and immunohistochemical results confirmed the diagnosis of EGIST. The patient received a radical prostatectomy, followed by targeted therapy with imatinib (400 mg, daily) for 1 year. Neither recurrence nor metastasis was detected at a 24-month follow-up.
Written by:
Ou Z, Cao Z, He Y, Tang D. Are you the author?
Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008.
Reference: Exp Ther Med. 2013 Aug;6(2):378-380.
doi: 10.3892/etm.2013.1156
PubMed Abstract
PMID: 24137192
UroToday.com Prostate Cancer Section
